Medical Devices Investors & VC Firms in Switzerland
78 firms in this list, with a median first check of $648K. 22 of them lead rounds. Generated from verified public data and updated continuously.
360 Capital
MilanPre-Seed–Series B$162K – $10.8M
38 people
Nextech Invest
ZurichSeed–Late Stage$648K – $3.2M
41 people
Kickfund
ZurichPre-Seed–Seed$950K
5 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
39 people
M Ventures
Los AngelesSeed–Growth$10.8M
9 people
SHS Capital
TübingenGrowth–Late Stage$10M – $50M
42 people
Nina Capital
BarcelonaPre-Seed–Series A$215K – $1.6M
21 people
HealthCap
StockholmSeed–Growth
30 people
Karista
ParisPre-Seed–Late Stage$324K – $5.4M
14 people
Novartis Venture Fund
BaselPre-Seed–Late Stage$5M – $25M
25 people
BioMedPartners
BaselSeed–Late Stage$648K – $6.5M
28 people
Beyond Capital Partners
Frankfurt am MainGrowth–Late Stage
24 people
Apollo Health Ventures
BerlinSeed–Series A
32 people
BONVENTURE
MünchenSeed–Series B$1M – $2.5M
21 people
VI Partners
AltendorfSeed–Series B$2.2M – $4.5M
15 people
MIG Capital AG
MunichSeed–Growth$1.1M – $10.8M
23 people
Ananda Impact Ventures
MunichPre-Seed–Series B$540K – $3.2M
18 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
24 people
Privilège Ventures
LuganoPre-Seed–Series A$100K – $1M
15 people
Planven Entrepreneur Ventures
ZurichSeed–Late Stage$10M – $20M
18 people
XGEN Venture
MilanPre-Seed–Series A
21 people
Delin Ventures
LondonPre-Seed–Series A$216K – $2.2M
21 people
Invivo Capital Partners
BarcelonaPre-Seed–Series A$2.2M – $4.3M
11 people
Kinled Holding
Hong KongSeed–Series A
1 person
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.



















































































